Clinical Trials Browser

Phase 1/2 × devimistat × Thoracic × Clear all

NCT03370159 2018-08-01

CPI-613 and Docetaxel in Treating Patients With Stage IIIB or IV Non-small Cell Lung Cancer

Phase 1/2 Withdrawn

Carcinoma, Non-Small-Cell Lung